2026 Global Patient Safety, Oncology TA Intern (PhD) jobs in United States
cer-icon
Apply on Employer Site
company-logo

AbbVie · 1 day ago

2026 Global Patient Safety, Oncology TA Intern (PhD)

AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The Global Patient Safety, Oncology Therapeutic Area Intern will support the enhancement of clinical safety insights and collaborate with various teams to improve non-clinical capabilities related to patient safety.

BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Collaborate with PST Leads and Preclinical Safety colleagues to identify gaps in current complex in vitro models (CIVM) and new approach methodologies (NAMs) capabilities as they relate to ongoing and potential clinical safety challenges
Partner with teams across Discovery, Development Biological Sciences, and Genomics, as well as external collaborators when appropriate, to enhance CIVM/NAMs and improve their utility in addressing clinical safety questions
Leverage reverse translatability to inform the development and refinement of non-clinical models based on clinical safety insights
Assist in the effective utilization and organization of data related to model capabilities and enhancements
Contribute to the overall goals of bridging gaps between non-clinical and clinical safety, helping to inform AbbVie’s R&D pipeline and clinical safety decision-making
Prepare summaries or presentations of findings and recommendations for internal stakeholders, demonstrating progress and impact on model capabilities

Qualification

Vitro modelsNew approach methodologiesReverse translatabilityData analysisCommunication skillsInitiative

Required

Currently enrolled in university, pursuing a PhD in biology, chemistry or related scientific discipline, or a programming or computational skill that is related to a scientific discipline, or other related degree
Must be enrolled in university for at least one semester following the internship
Experience with in vitro models (CIVM) and new approach methodologies (NAMs) capabilities
Ability to summarize complex information
Strong verbal and written communication skills
Takes initiative and always looks for improvement opportunities

Preferred

Expected graduation date between December 2026 – June 2027

Benefits

Competitive pay
Relocation support for eligible students
Opportunities for professional development and mentorship
Access to dynamic project experiences within a world-class pharmaceutical organization
Select wellness benefits and paid holiday / sick time

Company

AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.

H1B Sponsorship

AbbVie has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)

Funding

Current Stage
Public Company
Total Funding
$15B
2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO

Leadership Team

leader-logo
Robert Michael
Chairman of the Board and Chief Executive Officer
linkedin
leader-logo
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
linkedin
Company data provided by crunchbase